Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-28

Clinical Trial Update: Ficus Septica Leaves Fraction as a Complementary Therapy for Stadium IV Breast Cancer Patients [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for Ficus septica leaf fraction used as a complementary therapy in stage IV breast cancer (Phase 1/Phase 2).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ficus septica leaves fraction

Snippet

Sponsor: Gadjah Mada University | Conditions: Breast Cancer Stage IV | Phase 1, Phase 2 | Status: UNKNOWN